Transition from Parenteral to Oral Antimicrobial Therapy for Bacterial Pneumonia at Srinagarind Hospital

Main Article Content

Ratchadaporn Soontornpas
Piroon Mootsikapun
Cheardchai Soontornpas

Abstract

Use of parenteral antimicrobial in patient who can take oral medicines is a common non-rational antimicrobial use. Transition from parenteral to oral medicine must be done appropriately. The aim of this study was to collect the data about antimicrobial transition and assess its consistency to practice guideline for pneumonia of the American Thoracic Society and the Infectious Disease Society of America. Methods: This retrospective, descriptive study was performed in hospitalized patient with bacterial pneumonia at Srinagarind Hospital during 1 October 2016 to 30 September 2017. Data were collected from in-patient medical record and analyzed using descriptive statistics. Results: There were 110 patients eligible in the study. Community-acquired pneumonia, hospital-acquired pneumonia and both were diagnosed in 69.1, 26.4 and 4.5% of patients, respectively. Antibiotic prescribing was appropriated according to clinical practice guideline in term of type (76.5%) and dosage regimen (90.4%). Transition from parenteral to oral antimicrobial therapy was classified as step-down therapy (78.2%), sequential therapy (17.3%) and switch therapy (4.5%) and complied with clinical practice guideline in term of antimicrobial type (97.3%) and dosage regimen (93.6%). About 94.5% of patients had clinical improvement at hospital discharge. Conclusions: Antimicrobial transition for patients with bacterial pneumonia almost complied with practice guidelines and most patients had good clinical outcomes at hospital discharge.

Article Details

Section
Pharmaceutical Practice

References

Cunha CB. Antibiotic stewardship program perspective: oral antibiotic therapy for common infectious diseases. Med Clin N Am. 2018; 102: 947–54.

Gilbert DN, Chambers HF, Eliopoulos GM, Saag MS, Pavia AT. The Sanford guide to antimicrobial therapy 2017. 47th ed. 2017. Sperryville, VA: Antimicrobial Therapy; 2017.

Jongudomsuk P. Drug resistant microorganism: crisis and solution for Thai society. HSRI Forum. 2012; 1(1): 3–6.

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016; 63 (5): e61–e111.

Kuper KM. Intravenous to oral therapy conversion. In: Murdaugh LB. Competence assessment tools for health-system pharmacies. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2008. p. 347–60. [cited 2017 June 30]. Available from: http://ca.completerx.com/Study%20guides/IV%20to%20PO.pdf.

Limwattananon C, Sooksai N, Topark-Ngarm A, Waleekhachonloet O, Kitwiti P, Rattanachotphanit T, et al. Measures to promote rational use of medicines in public hospital: a review and analysis of national policy interventions. J Health Systems Research. 2013; 7(1): 33-44.

Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 (Suppl 2): S27-S72.

Muenpha R, Limwattananon C, Limwatananon S, Suwanakul P, Thangcharoensathien V. Promoting parenteral-oral drug switching for hospitalized patients. J Health Sci. 2006; 15(1): 80-93.

Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Van Kinh N, Wertheim HF. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014; 108(6): 326-37.

Reechaipichitkul W, Phondongnok S, Bourpoern J, Chaimanee P. Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand. Southeast Asian, J Trop Med Public Health. 2013; 44(3): 490-502.

Reechaipichitkul W. Management of pneumonia. KKUJM. 2015; 4: 17-29.

So-gern A, Meesing A, Jumpangern W. Update in diagnosis and management of hospital acquired pneumonia and ventilator associated pneumonia. KKUJM. 2019; 3: 12-25.

Yogo N, Hass MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol. 2015; 36(4): 474-8.